S-Methyl-L-cysteine

Names

[ Name ]:
S-Methyl-L-cysteine

[Synonym ]:
L-methylcysteine
(2R)-2-(Methylamino)-3-sulfanylpropanoic acid
S-METHYL-CYSTEINE
H-Cys(Me)-OH
SMC
Methylcysteine
DL-S-Methyl-cysteine
N-Methyl-L-cystein
Cysteine, N-methyl, L-
(R)-N-Methylcysteine
S-Methyl-L-cysteine
(2R)-2-amino-3-methylsulfanyl-propionic acid
EINECS 214-701-6
L-Cysteine, N-methyl-
L-Cysteine,S-methyl
N-Méthyl-L-cystéine
L-CH3SCH2CH(NH2)COOH
N-Methyl-L-cysteine
H-L-CYS(ME)-OH
MFCD00002612
(R)-2-Amino-3-(methylmercapto)propionic acid SMLC
S-Methyl-L-Cys-OH

Biological Activity

[Description]:

S-Methyl-L-cysteine is a natural product that acts as a substrate in the catalytic antioxidant system mediated by methionine sulfoxide reductase A (MSRA), with antioxidative, neuroprotective, and anti-obesity activities.

[Related Catalog]:

Signaling Pathways >> Others >> Others

Research Areas >> Metabolic Disease

Research Areas >> Neurological Disease

Natural Products >> Others

[In Vivo]

S-Methyl-L-cysteine (100 mg/kg) results in significant attenuation of plasma glucose, insulin, tumor necrosis factor-alpha, insulin resistance and improved antioxidant enzyme activities[1].

[References]

[1]. Thomas S, et al. Effect of s-methyl-L-cysteine on oxidative stress, inflammation and insulin resistance in male wistar rats fed with high fructose diet. Iran J Med Sci. 2015 Jan;40(1):45-50.

[Related Small Molecules]

Chemical & Physical Properties

[ Density]:
1.2±0.1 g/cm3

[ Boiling Point ]:
242.8±30.0 °C at 760 mmHg

[ Melting Point ]:
~240 °C (dec.)

[ Molecular Formula ]:
C₄H₉NO₂S

[ Molecular Weight ]:
135.185

[ Flash Point ]:
100.7±24.6 °C

[ Exact Mass ]:
135.035400

[ PSA ]:
88.62000

[ LogP ]:
0.47

[ Vapour Pressure ]:
0.0±1.0 mmHg at 25°C

[ Index of Refraction ]:
1.509

[ Storage condition ]:
-20°C

MSDS

Click to get detail MSDS

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Hazard Codes ]:
Xn: Harmful;

[ Risk Phrases ]:
R22

[ Safety Phrases ]:
S22-S24/25-S36/37/39-S26

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

DownStream

Articles

Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer.

PLoS ONE 10 , e0127063, (2015)

Expression of matrix metalloproteinase 9 (MMP9) is elevated in a variety of inflammatory and oncology indications, including ulcerative colitis and colorectal cancer. MMP9 is a downstream effector and...

Cysteine amide adduct formation from carboxylic acid drugs via UGT-mediated bioactivation in human liver microsomes.

Pharmazie 70 , 678-83, (2015)

Although chemical trapping has been widely used to evaluate cytochrome P450-mediated drug bioactivation, thus far, only a few in vitro-trapping studies have been performed on UDP-glucuronosyltransfera...

Synthesis and biological evaluation of L-cysteine derivatives as mitotic kinesin Eg5 inhibitors.

Bioorg. Med. Chem. Lett. 17 , 3921-4, (2007)

Inhibition of Eg5 represents a novel approach for the treatment of cancer. Here, we report the synthesis and structure-activity relationship of S-trityl-L-cysteine (STLC) derivatives as Eg5 inhibitors...

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.